Yan Zhao

机构：Beijing University of Chinese Medicine, Peking University, Peking University People's Hospital · ORCID：0000-0002-7198-0822

发表论文 136 篇 · 总被引 3341 次 · h-index 19

代表论文

• Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial (2024 · Allergy · 被引 30)
• Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents (2025 · JAMA Dermatology · 被引 20)
• Efficacy, drug survival, safety and metabolic parameters of ixekizumab in patients with moderate-to-severe psoriasis in China: A two-year real-world study (2024 · International Immunopharmacology · 被引 9)
• Long‐term survival analysis of patients with primary Sjögren's syndrome in China: A multicenter retrospective cohort study (2024 · International Journal of Rheumatic Diseases · 被引 9)
• Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study (2024 · Journal of the American Academy of Dermatology · 被引 6)
• Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis (2025 · Dermatitis · 被引 4)